Blogs
The reason tin prices are rising and 3 ASX stocks that provide the best exposure
Tin prices have been climbing sharply because the metal is suddenly caught between rising demand and tightening supply. Electronic devices, artificial intelligence hardware, solar panels and electric vehicles all rely on tin-based solder and components, pushing consumption higher just as long-neglected supply struggles to keep up. Production has been disrupted in key regions by political instability, mine closures and regulatory crackdowns, and underinvestment means new sources aren’t coming online fast enough. In this article we discuss some of the ASX stocks that can benefit the most from the rising tin prices.
3 ASX stocks with confirmed bullish divergence patterns
The Australian share market has a habit of sending quiet signals before a move actually happens. One of the most reliable of those signals is bullish divergence, a moment when price looks weak, but momentum quietly starts to improve. In this article, we’ll take a closer look at three stocks listed on the (ASX) that are currently showing confirmed bullish divergence patterns.
3 ASX Stocks on Solid Share Price Uptrends
Every so often, the market serves up a handful of charts that practically nudge you to take a closer look. You know the type, steady higher lows, clean breakouts, and that subtle shift in momentum that hints at a story unfolding beneath the surface. In this piece, we’re turning the spotlight on three ASX-listed stocks whose price action has been speaking in a clear and confident tone. These aren’t wild speculative swings or one-off spikes; they’re structured uptrends that have earned their place on watchlists through consistent behaviour.
National Australia Bank (ASX: NAB)- Business Banking Leverage, Deposit Power, and a Re-rating Setup into FY26–FY27
We believe National Australia Bank (ASX: NAB) is entering a structurally more attractive phase of its earnings cycle, one that the market is only partially pricing. FY25 confirms that NAB has completed a difficult multi-year transition from remediation-heavy execution towards balance-sheet-led growth, operational leverage, and disciplined capital deployment. In our view, National Australia Bank is no longer just a “solid major bank.” It is increasingly a business-banking-centric compounder, with improving margin resilience, strengthening deposit mix, stabilising asset quality, and credible technology-driven productivity optionality.
CSL Limited (ASX: CSL) – Structural Quality Re-Asserted
We believe CSL Limited (ASX: CSL) remains one of the highest-quality global healthcare franchises listed on the ASX, with FY25 marking a clear re-acceleration in earnings quality, cash flow conversion, and strategic clarity. While the share price has periodically struggled to reflect this underlying strength, we view CSL as misunderstood rather than mis-executing.
Collins Foods (ASX: CKF) - Why We Think CKF Is Entering Its Strongest Earnings Cycle Since Pre-COVID
We believe Collins Foods (ASX: CKF) is entering a multi-year earnings recovery cycle anchored by margin repair in Australia, operational rejuvenation in Europe, clear line-of-sight to double-digit EBITDA growth, and an improving balance sheet that gives management options rather than constraints. The HY26 results demonstrate that CKF is moving decisively out of the inflation shock period that suppressed margins and elevated operating costs between 2022–2024. With commodity and utilities inflation easing, labour efficiencies improving, and price/mix still resilient, we see structural tailwinds forming beneath the company’s operating base.
Why silver prices keep soaring, and how you can benefit from it on the ASX?
Silver has quietly moved into a powerful uptrend, and it’s not happening by accident. The metal is being pulled in two directions at once, as a financial haven and as an industrial workhorse. For ASX investors, this creates an opportunity. Exposure comes through producers, developers, and explorers whose revenues and valuations tend to rise as silver prices strengthen, offering leverage to a market driven by both fear and future-focused demand.
Commonwealth Bank of Australia (ASX: CBA) - Why We See Structural Strength in Australia’s Premium Bank
Commonwealth Bank of Australia (ASX: CBA) remains the undisputed heavyweight of the Australian financial system, dominant in retail banking, advantaged by scale, and well-positioned to monetise the next phase of household re-leveraging as rates peak and credit growth stabilises. Our view is simple: CBA’s franchise resilience is undervalued. While the macro backdrop remains mixed and competition in mortgages remains intense, the bank continues to deliver sector-leading returns, defend margin leadership, and maintain one of the strongest balance sheets globally.
LaserBond (ASX: LBL)- Engineered for Investors Seeking Durable Industrial Growth Exposure
LaserBond (ASX: LBL) has entered a structurally stronger period after FY25 delivered clear evidence of operating leverage, improved manufacturing efficiencies, and accelerating adoption of its surface-engineered technologies across mining, energy, defence, and agricultural markets. With its patented LaserBond® cladding and composite coating systems now demonstrating superior lifecycle economics versus traditional wear-resistance methods, the company is positioned as a high-margin engineering solutions provider rather than a cyclical industrial.
Sunrise Energy Metals (ASX: SRL) - Positioned at the Strategic Heart of Western Critical Minerals Supply Chains
Sunrise Energy Metals (ASX: SRL) is advancing one of the Western world’s most strategically significant battery-materials developments: the Sunrise Nickel-Cobalt-Scandium Project in NSW, a globally large, long-life, ESG-aligned source of critical minerals essential for EVs, aerospace alloys, defence technologies and high-performance fuel cells. Backed by strong balance sheet discipline, rising government engagement, escalating Western supply-security policies, and material advancement across strategic partnerships during 2025, Sunrise enters 2026 with a profile we view as deeply undervalued relative to its strategic optionality.
How Much Higher Can Recce Pharmaceuticals' (ASX: RCE) Share Price Go After the Recent Breakout?
Recce has recently attracted attention because it’s advancing drug candidates against serious infections, a space with significant potential if late-stage trials succeed. That kind of promise is why some market watchers see upside in RCE’s shares. On the flip side, the company remains unprofitable, with no consistent earnings or predictable cash flow, so it’s still a speculative biotech rather than a stable performer.
How Much Higher Can CETTIRE's (ASX: CTT) Share Price Go After the Recent Breakout?
Cettire (ASX: CTT) share price recently had a breakout. But it is in a bit of limbo; enough promise remains that a rebound could be on the cards, but enough uncertainty that it’s far from a safe bet. On one hand, the company is forecast to post healthy earnings-per-share growth over the next few years and has a pretty low price-to-sales ratio compared with peers, suggesting some latent value. On the other hand, consensus analyst targets hover modestly, some even see a drop, and many believe any upside beyond roughly one Australian dollar a share depends on improvements that aren’t guaranteed.
Macroeconomic Report for the Week Ending 5 December 2025 – Australian Market Outlook
Global data point to a softening but still mixed growth backdrop, with US manufacturing in mild contraction contrasted against resilient services activity. Labour indicators such as ADP employment and continuing jobless claims show cooling private hiring and more challenging re‑employment conditions, reinforcing expectations of earlier and deeper Federal Reserve rate cuts. Core US PCE inflation is running at a steady, moderate pace, allowing the Fed to stay on hold while waiting for clearer evidence that inflation is durably converging to the target.
Control Bionics (ASX: CBL) - This microcap's share price could explode higher from here!
The small-cap medical-tech company, Control Bionics, has just taken steps that could catapult it far beyond its current size. Its core product, a wearable sensor that translates even the faintest muscle or nerve signals into computer commands, is already approved and helps people with severe physical disabilities communicate and interact. Recently, the company announced that it had integrated a significant tech giant’s brain-computer interface protocol into its devices.
Investigator Silver (ASX: IVR)- Positions for Catalysts Amid Strengthening Silver Market
Investigator Silver (ASX: IVR), formerly known as Investigator Resources, is moving through one of the most strategically important phases in its history. The company is advancing the Paris Silver Project, Australia’s highest-grade undeveloped primary silver deposit, while simultaneously delivering exploration wins across its 100%-owned Peterlumbo tenement and progressing copper-gold targets at Uno Morgans.
NRW Holdings (ASX: NWH)-Positioned for Growth in FY26 and Beyond
NRW Holdings is emerging from FY25 with strengthened financial performance, record order book visibility, and renewed momentum across its mining, civil, and MET (Maintenance & Engineering) segments. With EBITDA growing, margins stabilising, and a robust pipeline supported by long-life Tier-1 resources projects, NWH has entered FY26 well-positioned for continued earnings expansion. The company’s durability across cycles, combined with strong cash generation and rising recurring revenue streams, reinforces the investment case for long-term holders.
3 ASX Stocks with Bullish Charts
When you spend enough time around the ASX, you start to notice a certain rhythm in how strong charts behave. Some stocks creep for weeks, building energy in tight ranges, and then, almost without announcement, they begin flashing early signs of strength. In this review, we focus on three ASX-listed companies whose price action suggests further upside.
Lithium Price Is on the Rise. Which ASX Lithium Stocks Offer Better Opportunities?
Lithium prices are rising again, which tends to lift investor interest in ASX-listed producers. Thanks to growing demand for batteries (EVs, energy storage) and tightening supply, analysts suggest the recent price upswing, roughly 20–25% month-on-month, may mark a turning point. In that context, some ASX companies with solid operations and cash flow stand out as offering relatively better risk-adjusted opportunities. Still, it’s not a guaranteed path: lithium remains a volatile commodity, and gains now reflect renewed optimism rather than long-term certainty.
3 ASX Stocks with Recent Bullish Breakouts
When you track the ASX day after day, you eventually spot those moments when a stock stops drifting and suddenly kicks into gear. A clear breakout, the kind that pushes past weeks of hesitation, often tells you buyers are finally taking control. In this article, we’re looking at three Australian companies whose share prices have recently surged through key resistance levels. These aren’t just quick spikes or one-day wonders. Each chart shows a pattern of tightening ranges, rising volume, and a decisive move that suggests momentum may continue.
Zip Co Limited (ASX: ZIP) — From BNPL Pioneer to Global Fintech Contender
Zip closed FY25 with what we consider a genuine inflection point: a record A$13.1bn in TTV and A$170.3m of group cash EBTDA — a level of profitability that would’ve sounded fanciful 18 months ago. The US arm is now the locomotive of the group, while ANZ has quietly rebuilt its margin spine. Momentum spilled straight into 1Q FY26, with TTV of A$3.9bn and cash EBTDA of A$62.8m, prompting management to hike US TTV guidance and expand the buyback to A$100m.
Macroeconomic Report for the Week Ending 28 November 2025 – Australian Market Outlook
The global macroeconomic backdrop shifted notably in the week ending 28 November 2025, fuelling a renewed "risk-on" sentiment that propelled a decisive recovery in Australian equities. In the United States, softening labour market indicators—specifically an acceleration in weekly ADP job losses—combined with a cooler-than-expected Core PPI reading and dovish commentary from Federal Reserve officials, led to a sharp repricing of interest rate expectations, with markets now pricing in an ~85% probability of a December cut. This pivot abroad overshadowed sticky domestic inflation data, allowing interest-rate-sensitive growth sectors to lead the S&P/ASX 200 higher, even as uncertainty persists around the Reserve Bank of Australia’s policy path.